British Journal of Haematology

HAEMOPOIETIC STEM CELL TRANSPLANTATION FROM UNRELATED DONORS
pp. 2-6(5)
Author: Heslop H.E.

INVESTIGATION OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD AND ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA BY MOLECULAR ANALYSIS
pp. 7-24(18)
Authors: Foroni L.; Harrison C.J.; Hoffbrand A.V.; Potter M.N.

THE HISTORY OF HAEMOPHILIA IN THE ROYAL FAMILIES OF EUROPE
pp. 25-32(8)
Author: Stevens R.F.

Recruitment of primitive peripheral blood cells: synergism of interleukin 12 with interleukin 6 and stem cell factor
pp. 33-39(7)
Authors: Grafte-Faure S.; Leveque C.; Vasse M.; Soria C.; Vannier J-P.

Expansion and differentiation of haemopoietic progenitor cells on endothelialized hydroxyapatite under static conditions
pp. 40-49(10)
Authors: Conrad V.; Dupouy M.; Bordenave L.; Lacombe F.; Baquey C.; Reiffers J.; Ripoche J.

Implication of expression of GDNF/Ret signalling components in differentiation of bone marrow haemopoietic cells
pp. 50-57(8)
Authors: Nakayama S.; Iida K-I.; Tsuzuki T.; Iwashita T.; Murakami H.; Asai N.; Iwata Y.; Ichihara M.; Ito S.; Kawai K.; Asai M.; Kurokawa K.; Takahashi M.

Spleen stromal cells support haemopoiesis and in vitro growth of dendritic cells from bone marrow
pp. 58-67(10)
Authors: Ni K.; O'Neill H.; O’Neill H.C.

Unexpected pattern of -globin mutations in -thalassaemia patients from northern Portugal
pp. 68-74(7)
Authors: Cabeda J.M.; Correia C.; Estevinho A.; Simões C.; Amorim A.L.; Pinho L.; JustiçA B.

A case of complete adenylate kinase deficiency due to a nonsense mutation in AK-1 gene (Arg 107 Stop, CGA TGA) associated with chronic haemolytic anaemia
pp. 75-79(5)
Authors: Bianchi P.; Zappa M.; Bredi E.; Vercellati C.; Pelissero G.; Barraco F.; Zanella A.

Detection of GPI-anchored protein-deficient cells in patients with aplastic anaemia and evidence for clonal expansion during the clinical course
pp. 80-84(5)
Authors: Kawaguchi K.; Wada H.; Mori A.; Takemoto Y.; Kakishita E.; Kanamaru A.

Paraproteins and monoclonal expansion of CD3⁺CD8⁺ CD56^-CD57⁺ T lymphocytes in a patient with HIV infection
pp. 85-87(3)
Authors: Smith P.; Helbert M.; Raftery M.; Forster G.; Cavenagh J.

Acquired APC resistance and oral contraceptives: differences between two functional tests
pp. 88-94(7)
Authors: Curvers J.; Thomassen M.C.L.G.D.; Nicolaes G.A.F.; van Oerle R.; Hamulyak K.; Coenraad HEMKER H.; Tans G.; Rosing J.

Risk of venous thromboembolism associated with the common hereditary haemochromatosis Hfe gene (C282Y) mutation
pp. 95-97(3)
Authors: Brown K.; Luddington R.; Taylor S.A.M.; Lillicrap D.P.; Baglin T.P.

The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss
pp. 98-101(4)
Authors: Holmes Z.R.; Regan L.; Chilcott I.; Cohen H.

Characterization of IgG monoclonal anti-cardiolipin/anti-₂GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies
pp. 102-109(8)
Authors: Zhu M.; Olee T.; Le D.T.; Roubey R.A.S.; Hahn B.H.; Woods Jr V.L.; Chen P.P.

Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study
pp. 110-116(7)
Authors: Rumley A.; Lowe G.D.O.; Sweetnam P.M.; Yarnell J.W.G.; Ford R.P.

Effect of the administration of recombinant hirudin and/or tissue-plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits
pp. 117-121(6)
Authors: Muñoz M.C.; Montes R.; Hermida J.; Orbe J.; Páramo J.A.; Rocha E.

Inadequacies in the postnatal management of fetomaternal alloimmune thrombocytopenia (FMAIT)
pp. 123-126(4)
Authors: Murphy M.F.; Verjee S.; Greaves M.

Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma
pp. 127-130(4)
Authors: Segeren C.M.; Sonneveld P.; van der Holt B.; Baars J.W.; Biesma D.H.; Cornellissen J.J.; Croockewit A.J.; Dekker A.W.; Fibbe W.E.; Löwenberg B.; van Marwijk Kooy M.; van Oers M.H.J.; Richel D.J.; Schouten H.C.; Vellenga E.; Verhoef G.E.G.; Wijermans P.W.; Wittebol S.; Lokhorst H.M.

MPC-1^-CD49e^- immature myeloma cells include CD45⁺ subpopulations that can proliferate in response to IL-6 in human myelomas
pp. 131-140(10)
Authors: FUJII R.; ISHIKAWA H.; MAHMOUD M.S.; ASAOKU H.; KAWANO M.M.

Recombinant human granulocyte-macrophage colony-stimulating factor plus erythropoietin for the treatment of cytopenias in patients with myelodysplastic syndromes
pp. 141-148(8)
Authors: Stasi R.; Pagano A.; Terzoli E.; Amadori S.; Dr Roberto Stasi

Significance of electron-dense deposits in the mitochondrial matrix of erythroid precursors in aplastic anaemia and myelodysplastic syndrome
pp. 149-154(6)
Authors: Bessho F.; Ohnishi H.; Tabuchi K.; Kobayashi M.; Hayashi Y.

Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children
pp. 155-162(8)
Authors: Xu F.; Taki T.; Yang H.W.; Hanada R.; Hongo T.; Ohnishi H.; Kobayashi M.; Bessho F.; Yanagisawa M.; Hayashi Y.

Leucocyte alkaline phosphatase identifies terminally differentiated normal neutrophils and its lack in chronic myelogenous leukaemia is not dependent on p210 tyrosine kinase activity
pp. 163-172(10)
Authors: Dotti G.; Garattini E.; Borleri G.; Masuhara K.; Spinelli O.; Barbui T.; Rambaldi A.

Characterization of T-cell receptor chain mRNA expression in IFN--responsive chronic myelogenous leukaemia patients
pp. 173-180(8)
Authors: Shimomura T.; Fujii S-I.; Ezaki I.; Osato M.; Fujimoto K.; Takatsuki K.; Yamamoto K.; Kawakita M.

Transendothelial migration of lymphocytes in chronic lymphocytic leukaemia is impaired and involved down-regulation of both L-selectin and CD23
pp. 181-189(9)
Authors: Chen J.R.; Gu B.J.; Dao L-P.; Bradley C.J.; Mulligan S.P.; Wiley J.S.

Molecular analysis of bcl-1/IgH junctional sequences in mantle cell lymphoma: potential mechanism of the t(11;14) chromosomal translocation
pp. 190-197(8)
Authors: Stamatopoulos K.; Kosmas C.; Belessi C.; Kyriazopoulos P.; Papadaki T.; Anagnostou D.; Loukopoulos D.

Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RAR rearrangement in newly diagnosed AML
pp. 198-207(10)
Authors: Allford S.; Grimwade D.; Langabeer S.; Duprez E.; Saurin A.; Chatters S.; Walker H.; Roberts P.; Rogers J.; Bain B.; Patterson K.; McKernan A.; Freemont P.; Solomon E.; Burnett A.; Goldstone A.; Linch D.

A novel translocation t(1;7)(p36;q34) in three patients with acute myeloid leukaemia
pp. 208-214(7)
Authors: Specchia G.; Cuneo A.; Liso V.; Contino R.; Pastore D.; Gentile E.; Rocchi M.; Castoldi G.L.

An association between mitochondrial function and all-trans retinoic acid-induced apoptosis in acute myeloblastic leukaemia cells
pp. 215-224(10)
Authors: Zheng A.; Mäntymaa P.; Säily M.; Siitonen T.; Savolainen E-R.; Koistinen P.

The RET receptor tyrosine kinase, but not its specific ligand, GDNF, is preferentially expressed by acute leukaemias of monocytic phenotype and is up-regulated upon differentiation
pp. 225-240(16)
Authors: Gattei V.; Degan M.; Rossi F.M.; De Iuliis A.; Mazzocco F.T.; Cesa E.; Aldinucci D.; Zagonel V.; Pinto A.

Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome
pp. 241-255(15)
Authors: Griesinger F.; Pirò-Noack M.; Kaib N.; Falk M.; Renziehausen A.; Troff C.; Grove D.; Schnittger S.; Büchner T.; Ritter J.; Hiddemann W.; Wörmann B.

Analysis of the region of the 5 end of the MLL gene involved in genomic duplication events
pp. 256-264(9)
Authors: Wiedemann L.M.; MacGregor A.; Caldas C.

High numbers of clonal CD19⁺ cells in the peripheral blood of a patient with multiple myeloma
pp. 265-267(3)
Authors: Rasmussen T.; Kastrup J.; Knudsen L.M.; Johnsen H.E.

Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2-deoxyadenosine
pp. 268-270(3)
Authors: Van Den Neste E.; Louviaux I.; Michaux J.L.; Delannoy A.; Michaux L.; Hagemeijer A.; Scheiff J.M.; Bosly A.; Straetmans N.; Ferrant A.

Serial serum thrombopoietin levels in a pregnant woman with essential thrombocythaemia
pp. 271-273(3)
Authors: Kanda Y.; Chiba S.; Tanaka Y.; Miwa A.; Togawa A.; Kato T.; Miyazaki H.; Nishino R.; Yazaki Y.; Hirai H.

Analysis of internal deletions within the BCL6 gene in B-cell non-Hodgkin's lymphoma
pp. 274-277(4)
Authors: Nakamura Y.; Saito K.; Furusawa S.

Paroxysmal cold haemoglobinuria caused by non-Hodgkin's lymphoma
pp. 278-279(2)
Authors: Sivakumaran M.; Murphy P.T.; Booker D.J.; Wood J.K.; Stamps R.; Sokol R.J.

Peripheral blood stem cell versus autologous bone marrow transplantation for Hodgkin's disease: equivalent survival outcome in a single-centre matched-pair analysis
pp. 280-287(8)
Authors: Perry A.R.; Peniket A.J.; Watts M.J.; Leverett D.; Goldstone A.H.; Linch D.C.

Pretransplant helper T-lymphocyte determination in bone marrow donors: acute graft-versus-host disease prediction and relation with long-term survival
pp. 288-294(7)
Authors: Winandy M.; Lewalle P.; Deneys V.; Ferrant A.; De Bruyère M.

Monitoring of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation
pp. 295-302(8)
Authors: Maeda Y.; Teshima T.; Yamada M.; Shinagawa K.; Nakao S.; Ohno Y.; Kojima K.; Hara M.; Nagafuji K.; Hayashi S.; Fukuda S.; Sawada H.; Matsue K.; Takenaka K.; Ishimaru F.; Ikeda K.; Niiya K.; Harada M.

A metalloproteinase inhibitor prevents acute graft-versus-host disease while preserving the graft-versus-leukaemia effect of allogeneic bone marrow transplantation
pp. 303-312(10)
Authors: Hattori K.; Hirano T.; Miyajima H.; Yamakawa N.; Ikeda S.; Yoshino K.; Tateno M.; Oshimi K.; Kayagaki N.; Yagita H.; Okumura K.

SUCCESSFUL AUTOLOGOUS BONE MARROW TRANSPLANTATION IN INTRAVASCULAR LYMPHOMATOSIS
pp. 313-314(2)
Authors: Rose C.; Staumont D.; Jouet J.P.